In a regulatory filing, the company states: "Recursion Pharmaceuticals confirms that it does not hold any deposits or securities or maintain any accounts at Silicon Valley Bank. We are currently evaluating counterparty risk and have discovered no material risk at this time."
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RXRX:
